Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001950915-22-000001
Filing Date
2022-10-17
Accepted
2022-10-17 17:03:42
Documents
1
Effectiveness Date
2022-10-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7465
  Complete submission text file 0001950915-22-000001.txt   8557
Mailing Address ONE KENDALL SQUARE BUILDING 400 SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 400 SUITE 201 CAMBRIDGE MA 02139 617-620-6280
Matchpoint Therapeutics Inc. (Filer) CIK: 0001950915 (see all company filings)

EIN.: 863144282 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-462017 | Film No.: 221314224